Modulation of Peripheral Inflammatory Pain Thresholds by M1 and Nicotinic Receptor Antagonists

Publisher： Karger

E-ISSN： 1423-0313|88|5-6|309-315

ISSN： 0031-7012

Source： Pharmacology, Vol.88, Iss.5-6, 2011-11, pp. : 309-315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interactions of a Dopamine D1 Receptor Agonist with Glutamate NMDA Receptor Antagonists on the Volitional Consumption of Ethanol by the mHEP Rat

By McMillen Brian A.   Lommatzsch Courtney L.   Sayonh Michael J.   Williams Helen L.  

Pharmaceuticals, Vol. 6, Iss. 4, 2013-03 ,pp. : 469-479

MDPI

Access to resources Recommend Favorite

Peripheral Control of Inflammatory but Not Neuropathic Pain by Endogenous Cholinergic System

By  

Pharmacology, Vol. 88, Iss. 1-2, 2011-07 ,pp. : 18-25

Karger

Access to resources Recommend Favorite

TRPV1 Antagonists and Chronic Pain: Beyond Thermal Perception

By Brandt Michael R.   Beyer Chad E.   Stahl Stephen M.  

Pharmaceuticals, Vol. 5, Iss. 2, 2012-02 ,pp. : 114-132

MDPI

Access to resources Recommend Favorite

Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2

By Yang Longhe   Li Yanting   Ren Jie   Zhu Chenggang   Fu Jin   Lin Donghai   Qiu Yan  

International Journal of Molecular Sciences, Vol. 15, Iss. 8, 2014-08 ,pp. : 13637-13648

MDPI

Access to resources Recommend Favorite

Modulation of Paracetamol and Nefopam Antinociception by Serotonin 5-HT3 Receptor Antagonists in Mice

By  

Pharmacology, Vol. 83, Iss. 4, 2009-03 ,pp. : 243-246

Karger

Access to resources Recommend Favorite